A Randomized, Double-blind, Placebo-controlled Cross-over Study to Investigate the Effect of GSK1014802 on Ambulatory Blood Pressure.
Phase of Trial: Phase I
Latest Information Update: 18 Oct 2017
At a glance
- Drugs Raxatrigine (Primary)
- Indications Bipolar disorders
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline
- 12 Jan 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 12 Jan 2010 Actual end date (Dec 2009) added as reported by ClinicalTrials.gov.
- 19 Aug 2009 New trial record